Hem › Hemofili › Florida › Tampa
Kliniska studier för Hemofili i Tampa, FL
4 studier för Hemofili söker deltagare vid platser i och runt Tampa (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
RekryterarFas 3
- USF Health Morsani Center For Advanced Healthcare, Tampa
- The University of South Florida Board of Trustees, Tampa
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
RekryterarFas 3
- St Joseph's Children's Hospital of Tampa, Tampa
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RekryterarObservationsstudie
- St. Joseph's Hospital Center for Bleeding & Clotting Disorders, Tampa
- University of South Florida - Adult, Tampa
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
RekryterarFas 1
- St. Joseph's Children's Hospital - Center for Bleeding and Clotting Disorders, Tampa
Hemofili-studier i andra städer
- Indianapolis, IN9 studier
- Los Angeles, CA7 studier
- Seattle, WA6 studier
- Cedar Rapids, IA6 studier
- Philadelphia, PA5 studier
- Little Rock, AR5 studier
- Sacramento, CA4 studier
- Dallas, TX4 studier
- Atlanta, GA4 studier
- Greenville, NC4 studier
- Orange, CA4 studier
- San Francisco, CA3 studier
Andra studier i Tampa
- Icke-småcellig lungcancer51 studier
- Bröstcancer43 studier
- Cancer (alla typer)39 studier
- Kolorektal cancer34 studier
- Akut myeloid leukemi29 studier
- Metastaserande cancer29 studier
- Lungcancer29 studier
- Bukspottkörtelcancer26 studier
- Äggstockscancer21 studier
- Melanom19 studier
- Myelodysplastiska syndrom19 studier
- Prostatacancer18 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.